Alnylam Pharmaceuticals Inc. will report its fourth quarter and full year 2025 financial results on Thursday, February 12, 2026, before U.S. financial markets open. Management will discuss the results and provide an update on company expectations in a conference call on February 12, 2026, at 8:30 am ET. A live audio webcast of the call will be available on the Investors section of the Company's website at https://www.alnylam.com/events. An archived webcast will be available on the Alnylam website approximately two hours after the event.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alnylam Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260129185762) on January 29, 2026, and is solely responsible for the information contained therein.